Oncology Clinical Trial Eligibility Expansion A Focus For US FDA; Sponsors Overcoming Initial Hesitation
US FDA plans to release a second set of guidances to industry; sponsors caution that tradeoffs need to be clear from onset.
US FDA plans to release a second set of guidances to industry; sponsors caution that tradeoffs need to be clear from onset.